TRACON Pharmaceuticals Inc. (TCON) is priced at $2.35 after the most recent trading session. At the very opening of the session, the stock price was $2.00 and reached a high price of $2.58, prior to closing the session it reached the value of $2.41. The stock touched a low price of $1.98.
Recently in News on August 31, 2020, TRACON Pharmaceuticals Announces Additional $5.0 Million Private Placement. TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., today announced that following the closing of the private placement announced on August 27, 2020, it has entered into an additional definitive securities purchase agreement with multiple institutional health care focused funds to raise aggregate gross proceeds of approximately $5.0 million through a private placement of its common stock and pre-funded warrants. The closing of the private placement is expected to occur on or about August 31, 2020. You can read further details here
TRACON Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.80 on 01/16/20, with the lowest value was $0.95 for the same time period, recorded on 03/16/20.
TRACON Pharmaceuticals Inc. (TCON) full year performance was -55.26%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, TRACON Pharmaceuticals Inc. shares are logging -58.77% during the 52-week period from high price, and 147.37% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.95 and $5.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 641437 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the TRACON Pharmaceuticals Inc. (TCON) recorded performance in the market was 2.99%, having the revenues showcasing 3.36% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 19.30M, as it employees total of 19 workers.
TRACON Pharmaceuticals Inc. (TCON) in the eye of market guru’s
During the last month, 0 analysts gave the TRACON Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.94, with a change in the price was noted +0.54. In a similar fashion, TRACON Pharmaceuticals Inc. posted a movement of +30.00% for the period of last 100 days, recording 777,607 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TCON is recording 1.50 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.93.
TRACON Pharmaceuticals Inc. (TCON): Stocks Technical analysis and Trends
Raw Stochastic average of TRACON Pharmaceuticals Inc. in the period of last 50 days is set at 76.70%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 76.70%. In the last 20 days, the company’s Stochastic %K was 67.93% and its Stochastic %D was recorded 51.29%.
If we look into the earlier routines of TRACON Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 2.99%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -12.04%, alongside a downfall of -55.26% for the period of the last 12 months. The shares increased approximately by 41.76% in the 7-day charts and went down by 43.45% in the period of the last 30 days. Common stock shares were driven by 3.36% during last recorded quarter.